Pfizer Inc. has submitted a sweetened bid for obesity drug startup Metsera Inc. as its fight against rival Novo Nordisk A/S continues to escalate, according to people familiar with the matter.
www.bloomberg.com
#Pfizer #Sweetens #Offer #Metsera #Bidding #War #Novo
Pfizer Sweetens Its Offer for Metsera in Bidding War Against Novo
